Sex differences in cardiovascular outcome during progression of aortic valve stenosis
Conclusions
In the SEAS study, women and men had similar rates of AS progression and AS-related events. However, women had lower total mortality and ischaemic CV event rate than men independent of confounders.
Trial registration number
ClinicalTrials.gov identifier: NCT00092677.
Source: Heart - Category: Cardiology Authors: Cramariuc, D., Rogge, B. P., Lonnebakken, M. T., Boman, K., Bahlmann, E., Gohlke-Barwolf, C., Chambers, J. B., Pedersen, T. R., Gerdts, E. Tags: Open access, Drugs: cardiovascular system, Echocardiography, Hypertension, Interventional cardiology, Aortic valve disease, Clinical diagnostic tests, Epidemiology Valvular heart disease Source Type: research
More News: Aortic Stenosis | Cardiology | Cardiovascular | Coronary Artery Bypass Graft | Epidemiology | Heart | Heart Disease | Hypertension | Ischemic Stroke | Simvastatin | Statin Therapy | Stroke | Study | Vytorin | Women | Zetia | Zocor